Targeted Genetics to Host Conference Call to Discuss the Recombinant DNA Advisory Committee (RAC) Review and the tgAAC94 Clinical Program
Posted on: Thursday, 13 September 2007, 18:00 CDT
Targeted Genetics Corporation (NASDAQ: TGEN) will report on the proceedings of the Recombinant DNA Advisory Committee (RAC) and the Company's tgAAC94 clinical program in inflammatory arthritis following the meeting on September 17, 2007.
In addition, management will host a conference call and webcast discussion on Tuesday, September 18, at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time. You may access the live webcast via the "Events" section of the Company's website at www.targetedgenetics.com or via telephone at 800-240-2430 (domestic) or 303-262-2131 (international).
The public RAC review is scheduled for Monday, September 17, beginning at 8:00 a.m. EDT. To review the agenda and access the live webcast of the RAC Review, link to: http://www4.od.nih.gov/oba/RAC/meeting.html.
Replay Access
Webcast replay will be available for approximately 30 days at www.targetedgenetics.com; telephone replay will be available approximately one hour following Tuesday's call through 11:59 p.m. PT, Tuesday, October 30, 2007, by calling 800.405.2236 (domestic) or 303.590.3000 (international); pass code 11097397#.
About Targeted Genetics
Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at www.targetedgenetics.com.
Investor and Media Contacts: Stacie D. Byars Director, Communications Targeted Genetics Corporation (206) 521-7392 Lori Murray Senior Associate WeissComm Partners (415) 946-1070
SOURCE: Targeted Genetics
Source: MARKET WIRE
Related Articles
- Targeted Genetics to Host Conference Call and Webcast Discussion of Third Quarter 2006 Results
- Targeted Genetics to Present at 2006 BIO Investor Forum
- Targeted Genetics to Host Conference Call and Webcast Discussion of Second Quarter 2006 Results
- Targeted Genetics to Present at the Needham & Company Fifth Annual Biotechnology and Medical Technology Conference
- Targeted Genetics to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference
- Targeted Genetics to Host Conference Call and Webcast Discussion of First Quarter 2006 Results on May 2, 2006
- Targeted Genetics to Webcast Presentation at the 8th Annual BIO CEO & Investor Conference on February 14, 2006
- Targeted Genetics to Present at the Rodman & Renshaw TechVest 7th Annual Healthcare Conference
- Targeted Genetics to Present At 2005 BIO InvestorForum
- Targeted Genetics to Present at Roth Capital Partners New York Conference
 |
 |
User Comments (0)
RSS Feeds